Other Publications

Yamey G, Schäferhoff M, Moran M, Diab M et al; (2020).  Developing an Aggregator Mechanism for Late-Stage Clinical Trials of Neglected Disease Product Candidates, Duke University, Center for International and Global Studies. SSRN

Moran M (2018)  Fixing Australia’s Global Health R&D Mess Development Policy Centre, Crawford School of Public Policy, Australian National University, Canberra

Moran M (2017) The Art of Saving Lives:  Getting ‘Global’ Right – Part 2 Development Policy Centre, Crawford School of Public Policy, Australian National University, Canberra

Moran M (2017)  The Art of Saving Lives:  Getting ‘Global’ Right – Part 1 Development Policy Centre, Crawford School of Public Policy, Australian National University, Canberra

Moran M (2016) The Grand Convergence: Closing the Divide between Public Health Funding and Global Health Needs. PLoS Biol 14(3): e1002363. doi:10.1371/journal.pbio.1002363

Røttingen J A, Regmi S, Eide M, Young A, Viergever R, Årdal C, Guzman J, Edwards D, Matlin S, Terry R (2013). Mapping available health R&D data: what’s there, what’s missing and what role for a Global Observatory. The Lancet. doi:10.1016/S0140-6736(13)61046-6

Moran M, Strub-Wourgaft N, Guzman J, Boulet P, Wu L, et al. (2011) Registering New Drugs for Low-Income Countries: The African Challenge. PLoS Med 8(2): e1000411. doi:10.1371/journal.pmed.1000411

Hanson K, Palafox B, Anderson S, Guzman J, Moran M, Shretta R, Wuliji T (2010). Pharmaceuticals. In: Merson M, Black R, Mills A Global Health: Diseases, Programs, Systems and Policies, 3rd ed. London: Jones and Bartlett.

Moran M, Guzman J, Ropars AL, Illmer A (2010). The role of Product Development Partnerships in research and development for neglected diseases. International Health. June 2010 (Vol. 2, Issue 2, Pages 114-122, DOI: 10.1016/j.inhe.2010.04.002)

Moran M (2010). Funding for research and development and the financial crisis. Lancet Infectious Diseases (10): 214-215.

Moran M, Guzman J, Henderson K, McDonald A, Omune B (2009). Giving innovation a push: public and philanthropic R&D funding. Global Forum Update on Research for Health 6. Global Forum for Health Research.

Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, et al. (2009) Neglected disease research and development: how much are we really spending? PLoS Med 6(2): e1000030

Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A, Potter S and Haile-Selassie H (2008) Clinical trial site capacity for malaria product development. Health Partnerships Review: Focusing collaborative efforts on research and innovation for the health of the poor. Global Forum for Health Research.

Moran M, Ropars AL, Guzman J (2007). Partnership dynamics, issues and challenges. Global Forum Update on Research for Health Volume 4. Global Forum for Health Research.

Moran M, Ropars AL, Guzman J (2007). Partnership dynamics, issues and challenges. Global Forum Update on Research for Health Volume 4. Global Forum for Health Research.

Moran M, Guzman J, Ropars A and Evans A (2007) Neglected Diseases, Doctors Can Make a Difference. British Medical Association.

Moran M and Guzman J (2006) Drug R&D for neglected diseases by public-private partnerships: are public funds appropriately distributed? Monitoring Financial Flows for Health Research 2005:Behind the Global Numbers. Global Forum for Health Research.

Moran M (2006) The New Landscape of Neglected Disease Drug Development. Annual Report 2005. Medicines for Malaria Venture.

Moran M and Guzman J (2005) Neglected disease drug development: How big is the gap? Forum 9. Global Forum for Health Research.